FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andreas Henke

Research Profile

Living Beings

Disorders

Anatomy

Cell Line

Chemicals & Drugs

Physiology

Virus Replication

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Alexander Rassmann; Hans-Peter Saluz; Ulrike Martin; Thomas Munder; Stefan Peter; Andreas Henke
Identification of gene expression profiles in HeLa cells and HepG2 cells infected with Coxsackievirus B3.
Andreas Sauerbrei; Roland Zell; Kathrin Bohn; Jan Simon Gronowitz; Andreas Henke; Kristin Liermann; Peter Wutzler
Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance.
Torsten Ginter; Thorsten Heinzel; Regine Heller; Andreas Henke; Dagmar Hildebrand; Shirley K Knauer; Katharina F Kubatzky; Theresa Liebe; Tobias Münz; Werner Reichardt; Johannes A Schmid; Roland H Stauber; Kalsoom Sughra; Carolin Bier; Oliver H Krämer
Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andreas Henke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alexander Rassmann; Hans-Peter Saluz; Ulrike Martin; Thomas Munder; Stefan Peter; Andreas Henke
Identification of gene expression profiles in HeLa cells and HepG2 cells infected with Coxsackievirus B3.
Journal of virological methods 2013;187(1):190-4.
2012: Andreas Sauerbrei; Roland Zell; Kathrin Bohn; Jan Simon Gronowitz; Andreas Henke; Kristin Liermann; Peter Wutzler
Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance.
Antiviral research 2012;96(2):105-7.
2012: Torsten Ginter; Thorsten Heinzel; Regine Heller; Andreas Henke; Dagmar Hildebrand; Shirley K Knauer; Katharina F Kubatzky; Theresa Liebe; Tobias Münz; Werner Reichardt; Johannes A Schmid; Roland H Stauber; Kalsoom Sughra; Carolin Bier; Oliver H Krämer
Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylation.
Cellular signalling 2012;24(7):1453-60.
2012: Katharina Sobotta; Nadine Wiesener; Steffi Wilsky; Peter Wutzler; Nadine Althof; Andreas Henke
Inhibition of nuclear factor kappa B activation reduces Coxsackievirus B3 replication in lymphoid cells.
Virus research 2012;163(2):495-502.
2012: Steffi Wilsky; Peter Wutzler; Nadine Althof; Thomas Munder; Johanna Pilas; Katharina Sobotta; Nadine Wiesener; Andreas Henke
Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication.
Archives of virology 2012;157(2):259-69.
2011: Nadine Wiesener; Peter Wutzler; Nadine Jarasch-Althof; Sara Lapp; Melissa Lehmann; Tatjana Schütze; Andreas Henke
Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
Viral immunology 2011;24(4):321-30.
2011: Nadine Wiesener; Christin Zimmer; Nadine Jarasch-Althof; Peter Wutzler; Andreas Henke
Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate.
Medical microbiology and immunology 2011;200(2):115-26.
2010: Nadine Jarasch-Althof; Nadine Wiesener; Michaela Schmidtke; Peter Wutzler; Andreas Henke
Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
Viral immunology 2010;23(4):369-76.
2008: Andreas Henke; Nadine Jarasch; Peter Wutzler
Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis.
Expert review of vaccines 2008;7(10):1557-67.
2008: Andreas Henke; Nadine Jarasch; Ulrike Martin; Roland Zell; Peter Wutzler
Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-gamma.
Viral immunology 2008;21(1):38-48.
2008: Andreas Henke; Nadine Jarasch; Ulrike Martin; Jenny Wegert; Anja Wildner; Roland Zell; Peter Wutzler
Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
International journal of medical microbiology : IJMM 2008;298(1-2):127-34.
2007: Alexander Rassmann; Andreas Henke; Nadine Jarasch; Friedrich Lottspeich; Hans-Peter Saluz; Thomas Munder
The human fatty acid synthase: a new therapeutic target for coxsackievirus B3-induced diseases?
Antiviral research 2007;76(2):150-8.
2007: Nadine Jarasch; Ulrike Martin; Roland Zell; Peter Wutzler; Andreas Henke
Influence of pan-caspase inhibitors on coxsackievirus B3-infected CD19+ B lymphocytes.
Apoptosis : an international journal on programmed cell death 2007;12(9):1633-43.
2007: Ulrike Martin; Nadine Jarasch; Matthias Nestler; Alexander Rassmann; Thomas Munder; Simone Seitz; Roland Zell; Peter Wutzler; Andreas Henke
Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3.
Apoptosis : an international journal on programmed cell death 2007;12(3):525-33.
2006: Alexander Rassmann; Andreas Henke; Monica Zobawa; Marc René Carlsohn; Hans-Peter Saluz; Susanne Grabley; Friedrich Lottspeich; Thomas Munder
Proteome alterations in human host cells infected with coxsackievirus B3.
The Journal of general virology 2006;87(Pt 9):2631-8.
2006: Holger H Sigusch; Michael H Lehmann; Dirk Reinhardt; Andreas Henke; Roland Zell; Carola Leipner; Hans R Figulla
Chemotactic activity of serum obtained from patients with idiopathic dilated cardiomyopathy.
Die Pharmazie 2006;61(8):706-9.
2006: Els Wessels; Daniël Duijsings; Ting-Kuang Niu; Steffi Neumann; Viola Oorschot; Frank de Lange; Kjerstin H W Lanke; Judith Klumperman; Andreas Henke; Catherine L Jackson; Willem J G Melchers; Frank J M van Kuppeveld
A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1.
Developmental cell 2006;11(2):191-201.
2006: Matthias Nestler; Ulrike Martin; Peter Hortschansky; Hans-Peter Saluz; Andreas Henke; Thomas Munder
The zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22.
Molecular and cellular biochemistry 2006;287(1-2):147-55.
2006: Andi Krumbholz; Astrid Meerbach; Roland Zell; Bernd Gruhn; Andreas Henke; Eckhard Birch-Hirschfeld; Peter Wutzler
Comparison of a LightCycler-based real-time PCR for quantitation of Epstein-Barr viral load in different clinical specimens with semiquantitative PCR.
Journal of medical virology 2006;78(5):598-607.
2006: Andreas Henke; Nadine Rohland; Roland Zell; Peter Wutzler
Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections.
Intervirology 2006;49(4):249-52.
2005: Roland Zell; Simone Seitz; Andreas Henke; Thomas Munder; Peter Wutzler
Linkage map of protein-protein interactions of Porcine teschovirus.
The Journal of general virology 2005;86(Pt 10):2763-8.
2005: Nadine Jarasch; Ulrike Martin; Esther Kamphausen; Roland Zell; Peter Wutzler; Andreas Henke
Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.
Viral immunology 2005;18(2):355-64.
2004: Andreas Henke; Chi-Shiun Chiang; Roland Zell; Axel Stelzner
Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice.
Antiviral research 2004;64(2):131-6.
2004: Anja Gastmann; Holger H Sigusch; Andreas Henke; Dirk Reinhardt; Ralf Surber; Oliver Gastmann; Hans R Figulla
Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
The American journal of cardiology 2004;93(10):1260-4.
2004: Roland Zell; René Markgraf; Michaela Schmidtke; Matthias Görlach; Axel Stelzner; Andreas Henke; Holger H Sigusch; Brigitte Glück
Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
Medical microbiology and immunology 2004;193(2-3):91-100.
2004: Ulrike Martin; Matthias Nestler; Thomas Munder; Roland Zell; Holger H Sigusch; Andreas Henke
Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions.
Medical microbiology and immunology 2004;193(2-3):133-9.
2003: Andreas Henke; Nadine Jarasch; Peter Wutzler
Vaccination procedures against Coxsackievirus-induced heart disease.
Expert review of vaccines 2003;2(6):805-15.
2003: Andreas Henke; Roland Zell; Ulrike Martin; Axel Stelzner
Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3.
Virology 2003;315(2):335-44.
2003: Andi Krumbholz; Rüdiger Wurm; Oliver Scheck; Eckhard Birch-Hirschfeld; Renate Egerer; Andreas Henke; Peter Wutzler; Roland Zell
Detection of porcine teschoviruses and enteroviruses by LightCycler real-time PCR.
Journal of virological methods 2003;113(1):51-63.
2003: Andreas Zautner; U Körner; Andreas Henke; C Badorff; Michaela Schmidtke
Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection.
Journal of virology 2003;77(18):10071-7.
2002: Andreas Henke
DNA immunization--a new chance in vaccine research?
Medical microbiology and immunology 2002;191(3-4):187-90.
2002: Ingrid Merkle; Mark J M van Ooij; Frank J M van Kuppeveld; Dirk H R F Glaudemans; Jochem M D Galama; Andreas Henke; Roland Zell; Willem J G Melchers
Biological significance of a human enterovirus B-specific RNA element in the 3' nontranslated region.
Journal of virology 2002;76(19):9900-9.
2002: Andi Krumbholz; Malte Dauber; Andreas Henke; Eckhard Birch-Hirschfeld; Nick J Knowles; Axel Stelzner; Roland Zell
Sequencing of porcine enterovirus groups II and III reveals unique features of both virus groups.
Journal of virology 2002;76(11):5813-21.
2001: Andreas Henke; Matthias Nestler; S Strunze; Hans-Peter Saluz; Peter Hortschansky; B Menzel; Ulrike Martin; Roland Zell; Axel Stelzner; Thomas Munder
The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva.
Virology 2001;289(1):15-22.
2001: Andreas Henke; Roland Zell; Gunter Ehrlich; Axel Stelzner
Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Journal of virology 2001;75(17):8187-94.
2001: Roland Zell; Malte Dauber; Andi Krumbholz; Andreas Henke; Eckhard Birch-Hirschfeld; Axel Stelzner; D Prager; Rüdiger Wurm
Porcine teschoviruses comprise at least eleven distinct serotypes: molecular and evolutionary aspects.
Journal of virology 2001;75(4):1620-31.
2001: Andreas Henke; Roland Zell; Axel Stelzner
DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice.
Antiviral research 2001;49(1):49-54.
2000: Roland Zell; Andi Krumbholz; Andreas Henke; Eckhard Birch-Hirschfeld; Axel Stelzner; M Doherty; Elizabeth Hoey; Malte Dauber; D Prager; Rüdiger Wurm
Detection of porcine enteroviruses by nRT-PCR: differentiation of CPE groups I-III with specific primer sets.
Journal of virological methods 2000;88(2):205-18.
2000: Holger H Sigusch; Ralf Surber; Michael H Lehmann; S Surber; J Weber; Andreas Henke; Dirk Reinhardt; A Hoffmann; Hans R Figulla
Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease.
Scandinavian journal of clinical and laboratory investigation 2000;60(3):229-35.
2000: Andreas Henke; Heike Launhardt; K Klement; Axel Stelzner; Roland Zell; Thomas Munder
Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva.
Journal of virology 2000;74(9):4284-90.
1999: Roland Zell; K Sidigi; Andreas Henke; J Schmidt-Brauns; Elizabeth Hoey; S Martin; Axel Stelzner
Functional features of the bovine enterovirus 5'-non-translated region.
The Journal of general virology 1999;80 ( Pt 9)():2299-309.
1998: Andreas Henke; E Wagner; J L Whitton; Roland Zell; Axel Stelzner
Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization.
Journal of virology 1998;72(10):8327-31.
1998: Rainer Wessely; Andreas Henke; Roland Zell; R Kandolf; Kirk U Knowlton
Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes.
Circulation 1998;98(5):450-7.
1995: Andreas Henke; S Huber; Axel Stelzner; J Lindsay Whitton
The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.
Journal of virology 1995;69(11):6720-8.
1993: A Bender; Hans Sprenger; J H Gong; Andreas Henke; G Bolte; H P Spengler; M Nain; Diethard Gemsa
The potentiating effect of LPS on tumor necrosis factor-alpha production by influenza A virus-infected macrophages.
Immunobiology 1993;187(3-5):357-71.
1992: H Renz; Andreas Henke; P Hofmann; L J Wolff; A Schmidt; J Rüschoff; Diethard Gemsa
Sensitization of rat alveolar macrophages to enhanced TNF-alpha release by in vivo treatment with dexamethasone.
Cellular immunology 1992;144(2):249-57.
1992: Andreas Henke; C Mohr; Hans Sprenger; C Graebner; Axel Stelzner; M Nain; Diethard Gemsa
Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(7):2270-7.
1992: Andreas Henke; H P Spengler; Axel Stelzner; M Nain; Diethard Gemsa
Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes.
Research in immunology 1992;143(1):65-70.
1991: Andreas Henke; M Nain; Axel Stelzner; Diethard Gemsa
Induction of cytokine release from human monocytes by coxsackievirus infection.
European heart journal 1991;12 Suppl D():134-6.